Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 37, which means every article in Journal of Diabetes & Metabolism has got 37 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
59 | 61 | 45 | 23 | 36 |
Year wise citations received |
844 | 899 | 793 | 852 | 764 |
| Journal total citations count | 7285 |
| Journal impact factor | 14.53 |
| Journal 5 years impact factor | 18.54 |
| Journal cite score | 18.02 |
| Journal h-index | 37 |
| Journal h-index since 2018 | 28 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Zuo C, Sheng X, Ma M, Xia M, Ouyang L. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget. 2016 Nov 8;7(45):74393. |
|
Gao J, Wang X, Song W, Wang YJ, Xiao YF. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part V. Diabetic Nephropathy and Effects of Angiotensin ? Receptor Antagonist Losartan. |
|
Gao J, Wang X, Song W, Wang YJ, Xiao YF. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part V. Diabetic Nephropathy and Effects of Angiotensin ? Receptor Antagonist Losartan. |
|
Gao J, Wang X, Song W, Wang YJ, Xiao YF. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part V. Diabetic Nephropathy and Effects of Angiotensin ? Receptor Antagonist Losartan. |
|
Albarazanji K, Nawrocki AR, Gao B, Wang X, Wang YJ, Xiao YF. Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates. Scientific Reports. 2021 Jun 4;11(1):1-4. |
|
Wikstrom J, Liu Y, Whatling C, Gan LM, Konings P, Mao B, Zhang C, Ji Y, Xiao YF, Wang Y. Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria. Journal of Diabetes and its Complications. 2021 Apr 1;35(4):107881. |
|
Liu Y, Gao J, Wang X, Wang YJ, Xiao YF. Dysglycemia and Dyslipidemia Models in Nonhuman Primates: Part III. Type I or II Diabetogenic Effects of Streptozocin J Diabetes Metab. 2019;10(3). |
|
Liu Y, Gu H, Wang H, Wang B, Wang X, Aoyagi G, Xiao YF, Chng K, Gao X, Wang J, Sho E. Hepatic steatosis and fibrosis in obese, dysmetabolic and diabetic nonhuman primates quantified by noninvasive echography. J Diabetes Metab. 2017 Oct 1;8(767):2. |
|
Wang B, Qiao W, Ye W, Wang X, Liu Y, Wang YJ, Xiao YF. Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates (Macaca Fascicularis). Scientific reports. 2017 Aug 29;7(1):1-0. |
|
Wang B, Sun G, Qiao W, Liu Y, Qiao J, Ye W, Wang H, Wang X, Lindquist R, Wang Y, Xiao YF. Long-term blood glucose monitoring with implanted telemetry device in conscious and stress-free cynomolgus monkeys. Journal of endocrinological investigation. 2017 Sep;40(9):967-77. |
|
Shubrook JH. Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy. The Journal of family practice. 2018 Aug 1;67(8 suppl):S49-54. |
|
Edelman SV. Glucagon-Like Peptide-1 Receptor Agonists. Journal of Family Practice. 2017 Oct 1;66(10):S12-. |
|
Skolnik NS, Jaffa F, Kiriakov Y. Individualizing dual therapy for type 2 diabetes mellitus. Hot Topics in Primary Care. 2017. |
|
Miller EM. Role of Injectable Medications in Type 2 Diabetes Treatment. Journal of Family Practice. 2017 Oct 1;66(10):S4-. |
|
Isaac AT, Du L, Chowdhury A, Xiaoke G, Lu Q, Yin X. Signaling pathways and proteins targeted by antidiabetic chalcones. Life Sciences. 2020 Dec 30:118982. |
|
Trautmann ME, Vora J. Use of glucagon?like peptide?1 receptor agonists among individuals on basal insulin requiring treatment intensification. Diabetic Medicine. 2018 Jun;35(6):694-706. |
|
Guja C, Frías JP, Somogyi A, Jabbour S, Wang H, Hardy E, Rosenstock J. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION?7 randomized study. Diabetes, Obesity and Metabolism. 2018 Jul;20(7):1602-14. |
|
Guja C, Frías JP, Somogyi A, Jabbour S, Wang H, Hardy E, Rosenstock J. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION?7 randomized study. Diabetes, Obesity and Metabolism. 2018 Jul;20(7):1602-14. |
|
Padhy J. Research & Reviews: Journal of Medical and Health Sciences. pancreas (the organ that produces insulin).;10:18. |
|
Padhy J. Research & Reviews: Journal of Medical and Health Sciences. pancreas (the organ that produces insulin).;10:18. |
|
